Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host DiseaseBadri Modi, Ryotaro Nakamura, Haris Ali et al.|Biology of Blood and Marrow Transplantation|2018Cited by 84
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agentsIbrahim Aldoss, Vinod Pullarkat, Sanjeet Dadwal et al.|Blood Advances|2019Cited by 84
Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant RecipientsHaris Ali, Monzr M. Al Malki, Dat Ngo et al.|Transplantation and Cellular Therapy|2021Cited by 78
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous LeukemiaKaramjeet Sandhu, Vinod Pullarkat, Sanjeet Dadwal et al.|Biology of Blood and Marrow Transplantation|2020Cited by 43